CN Stock MarketDetailed Quotes

603676 Tibet Weixinkang Pharmaceutical

Watchlist
  • 9.45
  • +0.03+0.32%
Market Closed May 17 15:00 CST
4.11BMarket Cap16.55P/E (TTM)

Tibet Weixinkang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-9.29%317.84M
-5.43%1.32B
-0.56%1.06B
12.18%749.41M
11.13%350.38M
35.31%1.4B
41.96%1.07B
33.63%668.04M
51.62%315.28M
44.43%1.03B
Operating revenue
-9.29%317.84M
-5.43%1.32B
-0.56%1.06B
12.18%749.41M
11.13%350.38M
35.31%1.4B
41.96%1.07B
33.63%668.04M
51.62%315.28M
44.43%1.03B
Other operating revenue
----
49.34%342.52K
----
98.01%227.08K
----
-23.04%229.36K
----
-24.94%114.68K
----
212.71%298.03K
Total operating cost
-11.15%256.01M
-4.44%1.18B
-0.17%893.3M
9.17%615.85M
4.25%288.12M
31.01%1.23B
33.28%894.8M
29.26%564.14M
49.83%276.37M
38.52%940.04M
Operating cost
-16.93%143.93M
-1.86%650.55M
4.37%529.44M
13.22%368.01M
12.87%173.26M
32.47%662.88M
35.29%507.28M
30.26%325.04M
52.01%153.51M
30.27%500.4M
Operating tax surcharges
-14.66%3.52M
-8.19%14.04M
-4.43%11.49M
10.49%8.03M
8.42%4.12M
28.07%15.29M
29.00%12.02M
22.53%7.27M
32.80%3.8M
37.54%11.94M
Operating expense
-12.83%55.55M
-18.19%255.42M
-18.88%190.57M
-2.30%137.06M
-12.40%63.73M
13.31%312.19M
23.55%234.93M
11.15%140.29M
32.39%72.75M
44.05%275.51M
Administration expense
-9.46%27.93M
-13.60%148.43M
-7.23%94.72M
-8.55%63.06M
-14.34%30.85M
50.58%171.78M
37.31%102.09M
63.27%68.95M
69.11%36.01M
60.21%114.08M
Financial expense
8.20%-844.59K
-42.55%-4.34M
-31.29%-3.08M
-24.36%-1.99M
-22.71%-920.06K
-3,540.15%-3.05M
-457.23%-2.35M
-534.21%-1.6M
-205.30%-749.75K
-53.01%88.52K
-Interest expense (Financial expense)
6.67%84.84K
80.61%342.29K
279.42%275.47K
386.12%176.88K
805.25%79.53K
65.08%189.52K
0.54%72.6K
-44.95%36.39K
-134.12%-11.28K
--114.8K
-Interest Income (Financial expense)
12.29%-897.06K
-47.73%-4.91M
-41.99%-3.54M
-35.97%-2.28M
-31.77%-1.02M
-67.76%-3.32M
-130.87%-2.49M
-128.30%-1.68M
-154.47%-776.2K
-79.61%-1.98M
Research and development
51.71%25.93M
55.71%112.82M
71.88%70.17M
72.24%41.68M
54.72%17.09M
90.57%72.45M
85.97%40.82M
98.80%24.2M
140.04%11.05M
63.91%38.02M
Credit Impairment Loss
-37.39%-1.27M
932.70%1.9M
-71.57%-2.46M
-165.30%-3.06M
-7.49%-925.22K
81.89%-228.37K
-79.89%-1.43M
67.58%-1.15M
74.41%-860.79K
-175.42%-1.26M
Asset Impairment Loss
97.82%-2.43K
97.01%-696.1K
98.39%-383.49K
-196.21%-315.99K
82.52%-111.56K
-353.82%-23.31M
-34,744.20%-23.75M
529.73%328.44K
-276.98%-638.15K
-413.72%-5.14M
Other net revenue
-21.81%3.26M
764.98%29.22M
174.87%9.24M
-23.60%5.87M
41.34%4.17M
-150.52%-4.39M
-230.30%-12.34M
254.42%7.69M
1,439.60%2.95M
-60.92%8.7M
Fair value change income
---618.22K
--11.58M
----
----
----
----
----
----
----
----
Invest income
-3.87%3.1M
-18.52%12.84M
-12.51%9.23M
-2.67%6.69M
-6.07%3.23M
39.13%15.76M
30.65%10.55M
42.99%6.87M
49.39%3.44M
-16.07%11.32M
Asset deal income
---7.38K
-373.30%-436.23K
-2,243.79%-293.04K
----
----
158.79%159.61K
-135.33%-12.5K
-127.52%-10.95K
----
488.47%61.68K
Other revenue
3.89%2.06M
24.83%4.04M
35.74%3.14M
55.04%2.57M
95.15%1.98M
-12.89%3.23M
4.14%2.32M
71.86%1.65M
97.32%1.02M
-54.26%3.71M
Operating profit
-2.01%65.09M
7.60%174.96M
10.68%177.11M
24.95%139.43M
58.65%66.43M
58.97%162.6M
78.10%160.02M
69.98%111.59M
79.86%41.87M
72.53%102.28M
Add:Non operating Income
36,690.73%41.97M
106.13%41.54M
1,383,790.72%41.52M
14,185.01%428.55K
--114.08K
41.67%20.15M
-99.98%3K
-99.78%3K
----
27.24%14.23M
Less:Non operating expense
823.35%481.43K
66.76%667.91K
-21.46%223.5K
-50.54%126.79K
51.36%52.14K
-82.45%400.52K
-81.94%284.57K
-61.29%256.34K
-94.72%34.45K
170.50%2.28M
Total profit
60.30%106.58M
18.36%215.84M
36.72%218.4M
25.51%139.73M
58.93%66.49M
59.64%182.36M
58.06%159.74M
67.80%111.33M
81.09%41.83M
64.07%114.23M
Less:Income tax cost
86.89%11.67M
-66.25%1.82M
-6.73%8.16M
-31.47%5.73M
113.69%6.24M
-70.54%5.4M
-53.21%8.75M
-35.80%8.36M
-35.75%2.92M
63.62%18.32M
Net profit
57.54%94.91M
20.94%214.02M
39.24%210.24M
30.13%134M
54.82%60.25M
84.50%176.96M
83.33%150.99M
93.10%102.97M
109.71%38.91M
64.16%95.91M
Net profit from continuing operation
57.54%94.91M
20.94%214.02M
39.24%210.24M
30.13%134M
54.82%60.25M
84.50%176.96M
83.33%150.99M
93.10%102.97M
109.71%38.91M
64.16%95.91M
Net profit of parent company owners
57.54%94.91M
20.94%214.02M
39.24%210.24M
30.13%134M
54.82%60.25M
84.50%176.96M
83.33%150.99M
93.10%102.97M
109.71%38.91M
64.16%95.91M
Earning per share
Basic earning per share
57.14%0.22
21.95%0.5
40.00%0.49
29.17%0.31
55.56%0.14
78.26%0.41
84.21%0.35
84.62%0.24
125.00%0.09
64.29%0.23
Diluted earning per share
57.14%0.22
21.95%0.5
40.00%0.49
29.17%0.31
55.56%0.14
78.26%0.41
84.21%0.35
84.62%0.24
125.00%0.09
64.29%0.23
Other composite income
-98.01%28.67K
115.46%779.4K
-36.96%8.17M
-34.09%4.55M
-64.75%1.44M
-177.81%-5.04M
1,105.40%12.95M
756.42%6.9M
1,740.46%4.09M
-52.93%6.48M
Other composite income of parent company owners
-98.01%28.67K
115.46%779.4K
-36.96%8.17M
-34.09%4.55M
-64.75%1.44M
-177.81%-5.04M
1,105.40%12.95M
756.42%6.9M
1,740.46%4.09M
-52.93%6.48M
Total composite income
53.91%94.94M
24.94%214.8M
33.22%218.41M
26.10%138.55M
43.44%61.69M
67.90%171.92M
102.22%163.94M
110.19%109.87M
134.92%43.01M
41.83%102.39M
Total composite income of parent company owners
53.91%94.94M
24.94%214.8M
33.22%218.41M
26.10%138.55M
43.44%61.69M
67.90%171.92M
102.22%163.94M
110.19%109.87M
134.92%43.01M
41.83%102.39M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -9.29%317.84M-5.43%1.32B-0.56%1.06B12.18%749.41M11.13%350.38M35.31%1.4B41.96%1.07B33.63%668.04M51.62%315.28M44.43%1.03B
Operating revenue -9.29%317.84M-5.43%1.32B-0.56%1.06B12.18%749.41M11.13%350.38M35.31%1.4B41.96%1.07B33.63%668.04M51.62%315.28M44.43%1.03B
Other operating revenue ----49.34%342.52K----98.01%227.08K-----23.04%229.36K-----24.94%114.68K----212.71%298.03K
Total operating cost -11.15%256.01M-4.44%1.18B-0.17%893.3M9.17%615.85M4.25%288.12M31.01%1.23B33.28%894.8M29.26%564.14M49.83%276.37M38.52%940.04M
Operating cost -16.93%143.93M-1.86%650.55M4.37%529.44M13.22%368.01M12.87%173.26M32.47%662.88M35.29%507.28M30.26%325.04M52.01%153.51M30.27%500.4M
Operating tax surcharges -14.66%3.52M-8.19%14.04M-4.43%11.49M10.49%8.03M8.42%4.12M28.07%15.29M29.00%12.02M22.53%7.27M32.80%3.8M37.54%11.94M
Operating expense -12.83%55.55M-18.19%255.42M-18.88%190.57M-2.30%137.06M-12.40%63.73M13.31%312.19M23.55%234.93M11.15%140.29M32.39%72.75M44.05%275.51M
Administration expense -9.46%27.93M-13.60%148.43M-7.23%94.72M-8.55%63.06M-14.34%30.85M50.58%171.78M37.31%102.09M63.27%68.95M69.11%36.01M60.21%114.08M
Financial expense 8.20%-844.59K-42.55%-4.34M-31.29%-3.08M-24.36%-1.99M-22.71%-920.06K-3,540.15%-3.05M-457.23%-2.35M-534.21%-1.6M-205.30%-749.75K-53.01%88.52K
-Interest expense (Financial expense) 6.67%84.84K80.61%342.29K279.42%275.47K386.12%176.88K805.25%79.53K65.08%189.52K0.54%72.6K-44.95%36.39K-134.12%-11.28K--114.8K
-Interest Income (Financial expense) 12.29%-897.06K-47.73%-4.91M-41.99%-3.54M-35.97%-2.28M-31.77%-1.02M-67.76%-3.32M-130.87%-2.49M-128.30%-1.68M-154.47%-776.2K-79.61%-1.98M
Research and development 51.71%25.93M55.71%112.82M71.88%70.17M72.24%41.68M54.72%17.09M90.57%72.45M85.97%40.82M98.80%24.2M140.04%11.05M63.91%38.02M
Credit Impairment Loss -37.39%-1.27M932.70%1.9M-71.57%-2.46M-165.30%-3.06M-7.49%-925.22K81.89%-228.37K-79.89%-1.43M67.58%-1.15M74.41%-860.79K-175.42%-1.26M
Asset Impairment Loss 97.82%-2.43K97.01%-696.1K98.39%-383.49K-196.21%-315.99K82.52%-111.56K-353.82%-23.31M-34,744.20%-23.75M529.73%328.44K-276.98%-638.15K-413.72%-5.14M
Other net revenue -21.81%3.26M764.98%29.22M174.87%9.24M-23.60%5.87M41.34%4.17M-150.52%-4.39M-230.30%-12.34M254.42%7.69M1,439.60%2.95M-60.92%8.7M
Fair value change income ---618.22K--11.58M--------------------------------
Invest income -3.87%3.1M-18.52%12.84M-12.51%9.23M-2.67%6.69M-6.07%3.23M39.13%15.76M30.65%10.55M42.99%6.87M49.39%3.44M-16.07%11.32M
Asset deal income ---7.38K-373.30%-436.23K-2,243.79%-293.04K--------158.79%159.61K-135.33%-12.5K-127.52%-10.95K----488.47%61.68K
Other revenue 3.89%2.06M24.83%4.04M35.74%3.14M55.04%2.57M95.15%1.98M-12.89%3.23M4.14%2.32M71.86%1.65M97.32%1.02M-54.26%3.71M
Operating profit -2.01%65.09M7.60%174.96M10.68%177.11M24.95%139.43M58.65%66.43M58.97%162.6M78.10%160.02M69.98%111.59M79.86%41.87M72.53%102.28M
Add:Non operating Income 36,690.73%41.97M106.13%41.54M1,383,790.72%41.52M14,185.01%428.55K--114.08K41.67%20.15M-99.98%3K-99.78%3K----27.24%14.23M
Less:Non operating expense 823.35%481.43K66.76%667.91K-21.46%223.5K-50.54%126.79K51.36%52.14K-82.45%400.52K-81.94%284.57K-61.29%256.34K-94.72%34.45K170.50%2.28M
Total profit 60.30%106.58M18.36%215.84M36.72%218.4M25.51%139.73M58.93%66.49M59.64%182.36M58.06%159.74M67.80%111.33M81.09%41.83M64.07%114.23M
Less:Income tax cost 86.89%11.67M-66.25%1.82M-6.73%8.16M-31.47%5.73M113.69%6.24M-70.54%5.4M-53.21%8.75M-35.80%8.36M-35.75%2.92M63.62%18.32M
Net profit 57.54%94.91M20.94%214.02M39.24%210.24M30.13%134M54.82%60.25M84.50%176.96M83.33%150.99M93.10%102.97M109.71%38.91M64.16%95.91M
Net profit from continuing operation 57.54%94.91M20.94%214.02M39.24%210.24M30.13%134M54.82%60.25M84.50%176.96M83.33%150.99M93.10%102.97M109.71%38.91M64.16%95.91M
Net profit of parent company owners 57.54%94.91M20.94%214.02M39.24%210.24M30.13%134M54.82%60.25M84.50%176.96M83.33%150.99M93.10%102.97M109.71%38.91M64.16%95.91M
Earning per share
Basic earning per share 57.14%0.2221.95%0.540.00%0.4929.17%0.3155.56%0.1478.26%0.4184.21%0.3584.62%0.24125.00%0.0964.29%0.23
Diluted earning per share 57.14%0.2221.95%0.540.00%0.4929.17%0.3155.56%0.1478.26%0.4184.21%0.3584.62%0.24125.00%0.0964.29%0.23
Other composite income -98.01%28.67K115.46%779.4K-36.96%8.17M-34.09%4.55M-64.75%1.44M-177.81%-5.04M1,105.40%12.95M756.42%6.9M1,740.46%4.09M-52.93%6.48M
Other composite income of parent company owners -98.01%28.67K115.46%779.4K-36.96%8.17M-34.09%4.55M-64.75%1.44M-177.81%-5.04M1,105.40%12.95M756.42%6.9M1,740.46%4.09M-52.93%6.48M
Total composite income 53.91%94.94M24.94%214.8M33.22%218.41M26.10%138.55M43.44%61.69M67.90%171.92M102.22%163.94M110.19%109.87M134.92%43.01M41.83%102.39M
Total composite income of parent company owners 53.91%94.94M24.94%214.8M33.22%218.41M26.10%138.55M43.44%61.69M67.90%171.92M102.22%163.94M110.19%109.87M134.92%43.01M41.83%102.39M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg